BioMed Central has published its first CME (Continuing Medical Education) webcast, in Arthritis Research & Therapy.

Clinical Conundrum: Use of COX-2 Inhibitors, nsNSAIDs and ASA in Patients with Cardiovascular Risk provides education to meet the needs of primary care physicians and rheumatologists.

The webcast is presented by Vibeke Strand, MD, from Stanford University with William B. White, MD from the University of Connecticut and R. Andrew Moore, DSc from the University of Oxford in the UK.

Supported by an educational grant from Pfizer, the program is designed to help physicians maintain and develop their knowledge, skills and practice.

Learning objectives

• Discuss the cardiovascular risks associated with non-selective and selective NSAIDs
• Review and compare of data on the effects of aspirin therapy in conjunction with NSAID therapies
• Summarize the UGI complications associated with nsNSAIDs and selective NSAIDs and the impact of concomitant administration of ASA
• Analyze of the benefit/risk profile of CV vs. GI events and explain in patient terminology

To participate and claim one CME credit*, please click here <arthritis-research.com/webcast/art-w1/>, register, and follow the instructions on the CME Information page.

For further information about publishing webcasts with BioMed Central, please contact us <info@biomedcentral.com>.

* This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of Medical Education Resources(https://www.mer.org/) and Innovations Consulting Group. Medical Education Resources is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation

Medical Education Resources designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.